About us

The history behind PainDrainer

The year was 2018 and Professor Carl Borrebaeck worked together with Doctor Maria Rosén Klement at Lund University in Sweden.

Maria, who herself lives with chronic pain, attended one of many programs in chronic pain rehabilitation. During the program, Maria realized that everyone who attended the program had the same problem. Every day is different, and the level of pain is affected by sleep and the many activities one is doing during the day. She realized that the pain is affected by far more parameters than the human brain can keep track of.

Maria shared her thoughts with Prof. Carl Borrebaeck, the difficulty of keeping track of the parameters affecting her pain and that advanced calculations should be able to calculate this. At this point, Maria and Carl decided to involve the IT specialist Göran Barkfors and together they began to explore the possibility of helping people with chronic pain understand their pain and thus being able to increase their quality of life through machine learning, i.e. artificial intelligence.

The goal was to create a tool that helps people with chronic, non-malignant pain to understand how different activities, and combinations of activities affect their pain level. With the aim to take control of their pain.

In the spring of 2021, PainDrainer’s pilot study was completed with very promising results. The chronic pain patients who participated in the study experienced increased quality of life and reduced pain level already after 6 weeks of using PainDrainer. 

The dream came through thanks to investors, pain management specialists and chronic pain patients who, just like Maria, Carl and Göran, wholeheartedly believes in the idea, that it can help millions of chronic pain patients to live a more fulfilled life and that it can be realized.

Watch the movie how the idea behind PainDrainer was born

Watch the story behind PainDrainer

Newsroom

Follow the latest new from PainDrainer.

Click here to see all the news.

THIS IS THE TEAM BEHIND PAINDRAINER

The right mix of competence and experience

Our board

Carl Borrebaeck

Chairman of the board
Professor Carl Borrebaeck, is a company builder who previously founded the Nasdaq listed companies Immunovia AB, Senzagen AB, BioInvent Int. AB, and Alligator BioScience AB. Carl Borrebaeck has been awarded a number of awards, such as AkzoNobel’s Science Prize (2009); Royal Engineering Academy Gold Medal (2012) for “his ground-breaking research on biomarkers” and he was appointed the Biotech Builder of the year 2017 for his entrepreneurship. He is the Director of CREATE Health Strategic Center for Translational Cancer Research, a permanent member of the Royal Academy of Engineering Sciences, and former vice president of Lund University. Carl Borrebaeck is also the Founding Mentor for Nordic Mentor Network for Entrepreneurship (NOME). Current appointments: Chairman of PainDrainer AB, SenzaGen AB, Immunovia AB and CB Ocean Capital AB. Board member of Alligator Bioscience AB, Qlucore AB and Scandion A/S.

Hans Lindroth

Board member
Hans Lindroth has extensive experience in venture investing, having had involvement in 60+ companies within IT, biotech and real estate development on four continents. Co-founder of several companies. He is heavily engaged in charitable activities in education, culture and social work; with a special mission on supporting deprived children. Speaker on new technology and new media. Former hockey player. 1987-88 Systems expert, Crosfield Electronics, 1988-1998 Various operational positions within the Marieberg/Bonnier Group. 1998- CEO of Lingfield AB – management company for holdings of the Peder Wallenberg Charitable Trust. Executive director of Carpe Vitam International and the Carpe Vitam Foundation. Board member of the Lemshaga Foundation. 2005- Special advisor and tech-investor for the Tamares Group. 2018- Financial advisor to the Svanberg family. 1987-88 Systems expert, Crosfield Electronics, 1988-1998 Various operational positions within the Marieberg/Bonnier Group. 1998- CEO of Lingfield AB – management company for holdings of the Peder Wallenberg Charitable Trust. Executive director of Carpe Vitam International and the Carpe Vitam Foundation. Board member of the Lemshaga Foundation. 2005- Special advisor and tech-investor for the Tamares Group. 2018- Financial advisor to the Svanberg family.

Peter Benson

Board member
Peter Benson led the formation of Sunstone Life Science Ventures and served as its Managing Partner from 2007-2019. In addition, Peter Benson has extensive experience from the Global Life Science industry as an investor, founder, board member and senior executive, including 10 listed companies. Previous positions include Head of Life Science Ventures at Vækstfonden (the Danish Growth Fund), President of the Hospital Care Division and Senior Vice President at Pharmacia AB as well as Executive Vice President Marketing & Sales at Kabi Pharmacia Parenterals.

Per Antonsson

Board member
Per Antonsson has a PhD in Medical Science and holds a Bachelor's Degree in Analytical Chemistry and Biochemistry from Lund University. As Investment Manager at Almi Invest, Per has long experience of business development and investment in start-up companies, preferably in life science. He has had several roles in pharmaceutical and biotechnology companies. Per is currently a board member of two other start-up companies in life science.

Mattias Ohlsson

Board member
Mattias Ohlsson is a professor at the department of Astronomy and Theoretical Physics, Lund University. He is also a professor of Information Technology at Halmstad University. Mattias research interests focus on AI and machine learning and its applications within the healthcare sector. Mattias has previous experience in developing AI based medical devices such as some of the products manufactured by Exini Diagnostics AB.

Erik Frick

CEO
Erik Frick has extensive experience of working with digital products and commercial work. He most recently held the position as COO & Vice President at Resurs Bank AB, where he worked with overall company strategies, business development, marketing and product development and was responsible for developing and commercializing their app in fintech with around a quarter of a million users. Erik also has experience as a board member of Kivra OY during their launch phase in the Finnish market. Erik has an MSc in Entrepreneurship and business design from Chalmers University of Technology.